Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the ...
20h
Tech Xplore on MSNMRI reveals real-time metal-ion dissolution in lithium batteries, offering insights into performance declineMany of the devices that make modern life convenient and efficient rely on rechargeable batteries. Lithium-ion batteries, one ...
Over time, batteries break down. Studying this process in-depth with imaging techniques may help us improve the lifespan of ...
an investigational gadolinium-based contrast agent (GBCA) for use in magnetic resonance imaging (MRI). All QUANTI studies investigated gadoquatrane at a gadolinium dose of 0.04 mmol Gd/kg body ...
Hosted on MSN1mon
Bayer MRI contrast agent gadoquatrane meets goals in phase 3 trialsBayer (OTCPK:BAYRY) said that phase 3 data on its experimental MRI contrast agent gadoquatrane met primary and secondary endpoints in phase 3 trials.The QUANTI studies examined gadoquatrane at a ...
Molecular imaging agents can be targeted to a specific receptor or protein on the cardiomyocyte surface, or to enzymes released into the interstitial space, such as cathepsins, matrix ...
Obtaining MRI data is a slow process, and acquisition times increase alongside higher spatial resolution when extensive volumetric coverage is needed and/or multiple contrast images or ...
Computed tomography (CT), Magnetic resonance imaging (MRI), Ultrasound, Positron emission tomography), By Agent Type (Radiopharmaceuticals, Contrast Media, Magnetic Resonance Imaging (MRI) Contrast ...
Dong Kook Lifescience lists on KOSDAQ, aims for 300 billion won by 2030 Dong Kook Lifescience seeks to enhance global presence by partnering with AI medical firms and developing innovative imaging ...
particularly MRI and CT scans, is not always an option, because of the high cost, lack of advanced equipment, and their adverse effects on the body: The contrast agents those methods rely on are ...
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results